Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2025

Jun 4, 2025

34491_dirs_2025-06-04_ca817a95-0464-4196-bf46-79472a8c8055.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-06-02

Reporting Person: Kelly John Alexander (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-02 Restricted Stock Units $ A 82750 Acquired Common Stock (82750) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.